Top Story

BioMed Central retracts 43 articles that used fabricated reviewers

March 31, 2015

Following an investigation which revealed attempts to manipulate the peer review process, medical and scientific publisher BioMed Central has retracted 43 articles that were published based on fabricated peer reviewers, the publisher announced in a statement on its blog.

“The apparent intention was to deceive editors and positively influence the outcome of peer review by suggesting fabricated reviewers,” Elizabeth Moylan, Senior Editor for Research Integrity at BioMed Central, wrote on the blog. “Given the scale of the deception, we alerted the Committee on Publication Ethics, and a number of other publishers.”

HBV found to mature infant immune systems In the Journals

HBV found to mature infant immune systems

March 31, 2015
Hepatitis B virus infection boosted immune system maturation among a cohort of infants in Singapore, according to newly published data in Nature
In the Journals

Healthy changes to microbiome persist after FMT for C. difficile infection

March 31, 2015
Patients who underwent fecal microbiota transplantation for Clostridium difficile infection had healthy, dynamic short- and long-term changes to their microbiome…
Meeting News Coverage

U.K. residents swimming in coastal waters may ingest resistant E. coli

March 31, 2015
United Kingdom residents who use coastal waters recreationally could be exposed to antibiotic resistant Escherichia coli, according to data presented at the General …
In the Journals

Testing, antivirals underutilized in older adults with suspected influenza

March 31, 2015
The use of antivirals was low among older adults hospitalized with the suspected virus in urban Tennessee, despite recommendations for the early initiation of these…
More News Headlines »
CME CNE CPE Video
Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

This activity is supported by an educational grant from Bristol-Myers Squibb.

Protease inhibitors (PIs) have played an instrumental role in decreasing mortality andmorbidity among HIV-infected…
More »
Meeting News Coverage Video
thumbnail for video 4129869191001

Video: NIAID Ebola vaccine well tolerated, immunogenic

March 23, 2015
WILMINGTON, Del. — Julie Ledgerwood, DO, of the National Institute of Allergy and Infectious Diseases' Vaccine…
More »
CME
Regimen Selection in HIV

Regimen Selection in HIV: Considering New Options to Optimize Outcomes
Monograph

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than 2 decades into the antiretroviral therapy (ART) era, numerous options are available for HIV treatment. The…
More »
morganatic-roan